erythromycin has been researched along with cefaclor anhydrous in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (33.33) | 18.7374 |
| 1990's | 29 (46.03) | 18.2507 |
| 2000's | 8 (12.70) | 29.6817 |
| 2010's | 5 (7.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bingen, E; Bourgeois, F; Doit, C; Lambert-Zechovsky, N; Mariani-Kurkdjian, P | 1 |
| Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
| McCarty, JM; Renteria, A | 1 |
| Nolen, TM | 1 |
| Dark, D | 1 |
| Kinasewitz, G; Wood, RG | 1 |
| Bluestone, CD; Mandel, EM; Nozza, RJ; Paradise, JL; Rockette, HE | 1 |
| Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
| Melton, D | 1 |
| Bedbeder, P; Boucherat, M; Bouhanna, CA; Cohen, R; de La Rocque, F; Geslin, P; Peynegre, R; Reinert, P | 1 |
| Kayser, FH; Morenzoni, G; Santanam, P | 2 |
| Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
| French, GL; Hui, YW; Khin-Thi-Oo, H; Ling, JM | 1 |
| Fujita, K; Sakata, H; Yoshioka, H | 1 |
| Noel, GJ; Teele, DW | 1 |
| Braveny, I; Dabernat, H; Dornbusch, K; Kayser, FH; Machka, K; Mittermayer, H; Perea, E; Powell, M; Van Dyck, E; Van Klingeren, B | 1 |
| Avlamis, A; Giamarellou, H; Kanellakopoulou, K | 1 |
| Doern, GV; Jorgensen, JH; Maher, LA; Preston, DA; Redding, JS; Thornsberry, C; Tubert, T | 1 |
| Ahronheim, G; Bergeron, MG; Bouchard, M; Bryer, D; Cron, C; Dempsey, EE; Macdonald, N; Richard, JE; Riding, K; Young, J | 1 |
| Barry, AL | 1 |
| Heulin, MG; Kalfon, P; Oréac, J; Sabbah, A | 1 |
| Chapin, KC; Doern, GV | 1 |
| Doern, GV; Jorgensen, JH; Preston, DA; Thornsberry, C | 1 |
| Kallings, I | 1 |
| Gezelius, L; Liljequist, BO | 1 |
| Stübner, G | 1 |
| Kayser, FH; Morenzoni, G; Wüst, J | 1 |
| Diamantstein, T; Hahn, H; Kuhring, D; Trautmann, M | 1 |
| Wiedemann, B | 1 |
| Forsgren, A; Walder, M | 1 |
| Carder, H; Clahsen, J; Culbertson, MC; Ginsburg, CM; Mcleland, O; Nelson, JD | 1 |
| Ginsburg, CM; Horner, DB; McCracken, GH; Zweighaft, TC | 1 |
| Klimek, JJ; Krause, PJ; Lehmann, WB; Nightingale, CH; Owens, NJ; Quintiliani, R | 1 |
| Ikeda, N | 1 |
| Konno, K; Nagai, A; Sakai, N; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
| McCarty, JM | 1 |
| Nolen, T | 1 |
| Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
| Brook, I | 1 |
| Chiesa, C; Nanni, F; Orefici, G; Pacifico, L | 1 |
| Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
| Lagrange, PH | 1 |
| Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
| Jradeh, M; Shihab, Z; Uwaydah, M | 1 |
| Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
| Groleau, EG; Kleemann, RL; Rigsbee, DR; Stephenson, GA; Xu, W | 1 |
| Hoover, J | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
| Aoshiba, K; Kohri, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Goss, TF; Najib, MM; Stein, GE | 1 |
| De Soyza, A; Gould, K; Higgins, B | 1 |
| Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G | 1 |
6 review(s) available for erythromycin and cefaclor anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
[Azithromycin, pharmacodynamic evaluation in animal models].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefaclor; Disease Models, Animal; Erythromycin; Legionnaires' Disease; Listeriosis; Lung Diseases; Mice; Mycobacterium avium; Parasitemia; Salmonella Infections, Animal; Tuberculosis | 1995 |
11 trial(s) available for erythromycin and cefaclor anhydrous
| Article | Year |
|---|---|
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Topics: Azithromycin; Bronchitis; Cefaclor; Erythromycin; Haemophilus Infections; Humans; Klebsiella Infections; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Prospective Studies; Sputum; Staphylococcal Infections; Streptococcal Infections | 1991 |
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Cefaclor; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
Comparative efficacy of erythromycin-sulfisoxazole, cefaclor, amoxicillin or placebo for otitis media with effusion in children.
Topics: Amoxicillin; Anti-Infective Agents; Cefaclor; Child; Child, Preschool; Drug Combinations; Erythromycin; Female; Humans; Infant; Male; Otitis Media with Effusion; Patient Compliance; Sulfisoxazole; Treatment Outcome | 1991 |
[An open randomized trial, Pediazole versus cefaclor in the treatment of acute otitis media in children].
Topics: Acute Disease; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Drug Combinations; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Recurrence; Streptococcal Infections; Streptococcus pneumoniae; Sulfisoxazole; Time Factors | 1991 |
Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
Topics: Acute Disease; Adolescent; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalexin; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Erythromycin; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella; Otitis Media with Effusion; Prospective Studies; Random Allocation; Recurrence; Streptococcus pneumoniae; Sulfisoxazole | 1987 |
Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Body Fluids; Cefaclor; Child; Child, Preschool; Ear, Middle; Erythromycin; Humans; Infant; Otitis Media; Penicillin V; Saliva; Tears; Trimethoprim | 1981 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Recurrent attacks of scarlet fever.
Topics: Amoxicillin; Cefaclor; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Penicillin V; Prospective Studies; Recurrence; Scarlet Fever | 1994 |
Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Topics: Adult; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cefaclor; Chlorides; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Membrane Potentials; Middle Aged; Rabbits; Sputum; Trachea | 2002 |
49 other study(ies) available for erythromycin and cefaclor anhydrous
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Child, Preschool; Clavulanic Acids; Colony Count, Microbial; Drug Therapy, Combination; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Staphylococcus aureus; Streptococcus pneumoniae; Sulfisoxazole | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Choosing antimicrobial therapy for otitis media.
Topics: Amoxicillin; Anti-Infective Agents; Cefaclor; Drug Combinations; Erythromycin; Humans; Otitis Media; Sulfisoxazole | 1991 |
The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Chloramphenicol Resistance; Drug Resistance, Microbial; Erythromycin; Europe; Haemophilus influenzae; Humans; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Prevalence of antimicrobial resistance in Haemophilus influenzae in Greece, Israel, Lebanon and Morocco.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Chloramphenicol Resistance; Drug Resistance, Microbial; Erythromycin; Greece; Haemophilus influenzae; Humans; Israel; Lebanon; Morocco; Serotyping; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Antimicrobial susceptibilities of Haemophilus species in Hong Kong.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Chloramphenicol; Chloramphenicol Resistance; Drug Resistance, Microbial; Erythromycin; Haemophilus; Haemophilus influenzae; Hong Kong; Humans; Species Specificity; Sputum; Tetracycline; Trimethoprim | 1989 |
The effect of antimicrobial agents on fecal flora of children.
Topics: Administration, Oral; Adolescent; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cephalosporins; Child; Child, Preschool; Erythromycin; Feces; Gentamicins; Humans; Infant; Injections, Intravenous; Methicillin; Penicillin V; Yeasts | 1986 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Chloramphenicol Resistance; Drug Resistance, Microbial; Erythromycin; Europe; Haemophilus influenzae; Humans; Tetracycline Resistance | 1988 |
Surveillance study of resistance in Haemophilus species in Greece.
Topics: Adult; Aged; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Chloramphenicol; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Greece; Haemophilus; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Middle Aged; Sputum; Sulfamethoxazole; Tetracycline; Tetracycline Resistance; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefamandole; Cephalexin; Cephalothin; Chloramphenicol Resistance; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Rifampin; Sulfamethoxazole; Tetracycline Resistance; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1988 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
[Cell-mediated immunity in antibiotic therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Double-Blind Method; Erythromycin; Humans; Immunity, Cellular; Immunity, Innate; Infections; Lymphocyte Activation; Rosette Formation; Statistics as Topic | 1988 |
Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
Topics: Adolescent; Adult; Age Factors; Aged; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefamandole; Cephalothin; Child; Child, Preschool; Chloramphenicol; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Tetracycline; United States | 1986 |
Sensitivity of Branhamella catarrhalis to oral antibiotics.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefaclor; Drug Combinations; Erythromycin; Humans; Microbial Sensitivity Tests; Neisseriaceae; Penicillins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
[The effect of subinhibitory concentrations of cefaclor, erythromycin and doxycycline on phagocytosis and intracellular killing of E. coli by human neutrophil granulocytes].
Topics: Anti-Bacterial Agents; Cefaclor; Doxycycline; Erythromycin; Escherichia coli; Humans; In Vitro Techniques; Kinetics; Luminescent Measurements; Neutrophils; Phagocytosis | 1986 |
[Antibiotic resistance and serotypes of Streptococcus pneumoniae in Zurich (1984-1985)].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Serotyping; Streptococcal Infections; Streptococcus pneumoniae; Sulfamethoxazole; Switzerland; Tetracycline; Trimethoprim | 1987 |
[The effect of cefaclor, doxycycline and other oral antibiotics on phagocytosis of polymorphonuclear granulocytes and PHA-induced stimulation of blood lymphocytes in man].
Topics: Anti-Bacterial Agents; Cefaclor; Cell Division; Dose-Response Relationship, Drug; Doxycycline; Drug Combinations; Erythromycin; Humans; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Neutrophils; Phagocytosis; Phytohemagglutinins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
[Comparison of the activity of cefaclor with amoxicillin, erythromycin and doxycycline in an in vitro model].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cephalexin; Doxycycline; Erythromycin; Escherichia coli; Microbial Sensitivity Tests; Time Factors | 1983 |
Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Dose-Response Relationship, Drug; Doxycycline; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Neisseria; Penicillin Resistance; Penicillin V; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
A comparison of three antibiotic regimens for eradication of Haemophilus influenzae type b from the pharynx of infants and children.
Topics: Carrier State; Cefaclor; Child; Drug Therapy, Combination; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Pharyngitis; Rifampin; Sulfisoxazole | 1980 |
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Drug Therapy, Combination; Ear, Middle; Erythromycin; Humans; Infant; Otitis Media; Otitis Media with Effusion; Sulfamethoxazole; Sulfisoxazole; Trimethoprim | 1982 |
[Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae from clinical specimens].
Topics: Cefaclor; Drug Resistance, Microbial; Erythromycin; Humans; Ofloxacin; Oxacillin; Penicillin Resistance; Serotyping; Streptococcus pneumoniae | 1995 |
Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs.
Topics: Ampicillin; Animals; Capillary Permeability; Cefaclor; Coloring Agents; Dose-Response Relationship, Drug; Endotoxins; Erythromycin; Indoles; Lung; Male; Microcirculation; Neutrophils; Organ Size; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Trachea | 1995 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
Management of chronic suppurative otitis media: superiority of therapy effective against anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Cefaclor; Chronic Disease; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Infant, Newborn; Otitis Media, Suppurative; Retrospective Studies | 1994 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon.
Topics: Amoxicillin; Cefaclor; Ceftriaxone; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lebanon; Penicillin G; Streptococcus pneumoniae; Tetracycline | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Formation of isomorphic desolvates: creating a molecular vacuum.
Topics: Absorption; Calorimetry; Cefaclor; Cephalexin; Enalapril; Erythromycin; Models, Molecular; Molecular Structure; Powders; Solubility; Water; X-Ray Diffraction | 1998 |
"Antibiotic selection for endodontic infections".
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cephalexin; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Erythromycin; Humans; Patient Care Planning; Penicillin V; Periapical Diseases | 1995 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefaclor; Clarithromycin; Dose-Response Relationship, Drug; Erythromycin; Gene Expression Regulation, Enzymologic; Humans; Josamycin; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
An unusual case of pulmonary abscess.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Brain Abscess; Cefaclor; Cephalosporins; Diagnosis, Differential; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Metronidazole; Penicillins; Periodontal Abscess; Thoracic Vertebrae; Tomography, X-Ray Computed | 2000 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections | 2015 |